Adagio Medical (Nasdaq:ADGM) announced today that it received FDA investigational device exemption (IDE) to expand its ...

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the U.S.

J&J Medtech has launched the latest version of its pulsed ablation device after receiving CE Mark approval in Europe. The ...

The Varipulse Pro pulsed field ablation platform, which has received a CE mark, will be a focus at the upcoming European ...

A local doctor with a heart rhythm problem turns to a colleague for help and a new procedure to treat the issue.

Johnson & Johnson announced launch of VARIPULSE Pro in Europe following CE Mark approval, further advancing its pulsed field ...

Working with "digital twins" of patients' hearts, doctors improved cardiac ablation outcomes for patients with ...

Catheter ablation tools A retrospective study revealed no significant difference in 36-month progression-free survival and renal function outcomes in patients with small renal masses. Microwave ...

Compared with medical therapy, rhythm control with catheter ablation is associated with lower risk of ischemic stroke after 30 days, as well as less mortality and heart failure (HF) hospitalization, ...